Dual-Function Polymeric HPMA Prodrugs for the Delivery of miRNA

Zheng Hong Peng, Ying Xie, Yan Wang, Jing Li, David Oupicky

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

An HPMA-based polymeric prodrug of a CXCR4 antagonist, AMD3465 (P-SS-AMD), was developed as a dual-function carrier of therapeutic miRNA. P-SS-AMD was synthesized by a copolymerization of HPMA with a methacrylamide monomer in which the AMD3465 was attached via a self-immolative disulfide linker. P-SS-AMD showed effective release of the parent AMD3465 drug following treatment with intracellular levels of glutathione (GSH). The AMD3465 was released in the cells and exhibited functional CXCR4 antagonism, demonstrated by inhibition of the CXCR4-mediated cancer cell invasion. Due to its cationic character, P-SS-AMD could form polyplexes with miRNA and mediate efficient transfection of miR-200c mimics to downregulate expression of a downstream target ZEB-1 in cancer cells. The combined P-SS-AMD/miR-200c polyplexes showed improved ability to inhibit cancer cell migration when compared with individual treatments. The reported findings validate P-SS-AMD as a dual-function delivery vector that can simultaneously deliver a therapeutic miRNA and function as a polymeric prodrug of CXCR4 antagonist.

Original languageEnglish (US)
Pages (from-to)1395-1404
Number of pages10
JournalMolecular Pharmaceutics
Volume14
Issue number5
DOIs
StatePublished - May 1 2017

Fingerprint

hydroxypropyl methacrylate
Prodrugs
MicroRNAs
Neoplasms
Disulfides
Cell Movement
Transfection
Glutathione
Down-Regulation
N-(1,4,8,11- tetraazacyclotetradecanyl-1,4-phenylenebis(methylene))-2-(aminomethyl)- pyridine
Therapeutics

Keywords

  • CXCR4 antagonist
  • miRNA delivery
  • polymeric prodrug
  • polyplexes
  • self-immolative linker

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Cite this

Dual-Function Polymeric HPMA Prodrugs for the Delivery of miRNA. / Peng, Zheng Hong; Xie, Ying; Wang, Yan; Li, Jing; Oupicky, David.

In: Molecular Pharmaceutics, Vol. 14, No. 5, 01.05.2017, p. 1395-1404.

Research output: Contribution to journalArticle

Peng, Zheng Hong ; Xie, Ying ; Wang, Yan ; Li, Jing ; Oupicky, David. / Dual-Function Polymeric HPMA Prodrugs for the Delivery of miRNA. In: Molecular Pharmaceutics. 2017 ; Vol. 14, No. 5. pp. 1395-1404.
@article{5c6dee34de5648f0a9d141854c2631ee,
title = "Dual-Function Polymeric HPMA Prodrugs for the Delivery of miRNA",
abstract = "An HPMA-based polymeric prodrug of a CXCR4 antagonist, AMD3465 (P-SS-AMD), was developed as a dual-function carrier of therapeutic miRNA. P-SS-AMD was synthesized by a copolymerization of HPMA with a methacrylamide monomer in which the AMD3465 was attached via a self-immolative disulfide linker. P-SS-AMD showed effective release of the parent AMD3465 drug following treatment with intracellular levels of glutathione (GSH). The AMD3465 was released in the cells and exhibited functional CXCR4 antagonism, demonstrated by inhibition of the CXCR4-mediated cancer cell invasion. Due to its cationic character, P-SS-AMD could form polyplexes with miRNA and mediate efficient transfection of miR-200c mimics to downregulate expression of a downstream target ZEB-1 in cancer cells. The combined P-SS-AMD/miR-200c polyplexes showed improved ability to inhibit cancer cell migration when compared with individual treatments. The reported findings validate P-SS-AMD as a dual-function delivery vector that can simultaneously deliver a therapeutic miRNA and function as a polymeric prodrug of CXCR4 antagonist.",
keywords = "CXCR4 antagonist, miRNA delivery, polymeric prodrug, polyplexes, self-immolative linker",
author = "Peng, {Zheng Hong} and Ying Xie and Yan Wang and Jing Li and David Oupicky",
year = "2017",
month = "5",
day = "1",
doi = "10.1021/acs.molpharmaceut.6b00999",
language = "English (US)",
volume = "14",
pages = "1395--1404",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Dual-Function Polymeric HPMA Prodrugs for the Delivery of miRNA

AU - Peng, Zheng Hong

AU - Xie, Ying

AU - Wang, Yan

AU - Li, Jing

AU - Oupicky, David

PY - 2017/5/1

Y1 - 2017/5/1

N2 - An HPMA-based polymeric prodrug of a CXCR4 antagonist, AMD3465 (P-SS-AMD), was developed as a dual-function carrier of therapeutic miRNA. P-SS-AMD was synthesized by a copolymerization of HPMA with a methacrylamide monomer in which the AMD3465 was attached via a self-immolative disulfide linker. P-SS-AMD showed effective release of the parent AMD3465 drug following treatment with intracellular levels of glutathione (GSH). The AMD3465 was released in the cells and exhibited functional CXCR4 antagonism, demonstrated by inhibition of the CXCR4-mediated cancer cell invasion. Due to its cationic character, P-SS-AMD could form polyplexes with miRNA and mediate efficient transfection of miR-200c mimics to downregulate expression of a downstream target ZEB-1 in cancer cells. The combined P-SS-AMD/miR-200c polyplexes showed improved ability to inhibit cancer cell migration when compared with individual treatments. The reported findings validate P-SS-AMD as a dual-function delivery vector that can simultaneously deliver a therapeutic miRNA and function as a polymeric prodrug of CXCR4 antagonist.

AB - An HPMA-based polymeric prodrug of a CXCR4 antagonist, AMD3465 (P-SS-AMD), was developed as a dual-function carrier of therapeutic miRNA. P-SS-AMD was synthesized by a copolymerization of HPMA with a methacrylamide monomer in which the AMD3465 was attached via a self-immolative disulfide linker. P-SS-AMD showed effective release of the parent AMD3465 drug following treatment with intracellular levels of glutathione (GSH). The AMD3465 was released in the cells and exhibited functional CXCR4 antagonism, demonstrated by inhibition of the CXCR4-mediated cancer cell invasion. Due to its cationic character, P-SS-AMD could form polyplexes with miRNA and mediate efficient transfection of miR-200c mimics to downregulate expression of a downstream target ZEB-1 in cancer cells. The combined P-SS-AMD/miR-200c polyplexes showed improved ability to inhibit cancer cell migration when compared with individual treatments. The reported findings validate P-SS-AMD as a dual-function delivery vector that can simultaneously deliver a therapeutic miRNA and function as a polymeric prodrug of CXCR4 antagonist.

KW - CXCR4 antagonist

KW - miRNA delivery

KW - polymeric prodrug

KW - polyplexes

KW - self-immolative linker

UR - http://www.scopus.com/inward/record.url?scp=85018455043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018455043&partnerID=8YFLogxK

U2 - 10.1021/acs.molpharmaceut.6b00999

DO - 10.1021/acs.molpharmaceut.6b00999

M3 - Article

C2 - 28134535

AN - SCOPUS:85018455043

VL - 14

SP - 1395

EP - 1404

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 5

ER -